Roflumilast Tablet
Product Images NDC 67877-480

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 67877-480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rof-250mcg-500s-a (Rof 250mcg 500s A)

Label for Roflumilast Tablets 250 mcg by Ascend Laboratories, LLC. The label includes dosage instructions recommending a starting dose of one 250 mcg tablet daily for 28 days, storage conditions, and safety warnings. It indicates the package contains 500 tablets and is marked Rx Only. Manufacturer is Alkem Laboratories, India, with distribution by Ascend Laboratories, NJ.*

FDA Label Image

Rof-250mcg-blister (Rof 250mcg Blister)

A blister pack label for Roflumilast Tablet 250 micrograms by Ascend Laboratories, LLC. The label includes daily dosage indications for Sunday through Wednesday, with each day associated with a 250 mcg tablet. It contains instructions for use during the first 28 days and warnings not to remove tablets from the blister until immediately prior to administration. The NDC number 67877-730-32 is visible on each tablet section along with a placeholder for lot number and expiration date.*

FDA Label Image

Rof-250mcg-carton-28s-b (Rof 250mcg Carton 28s B)

Roflumilast Tablets 250 mcg oral tablet packaging label for a 28-day supply with 28 unit-dose tablets (4 x 7). Labeler is Ascend Laboratories, LLC. The label includes storage instructions, dosage notice, warnings, and manufacturer details (Alkem Laboratories Ltd., Mumbai, India).*

FDA Label Image

Rof01 (Rof01)

Chemical structure of Roflumilast, the active ingredient, showing its molecular framework including aromatic rings, fluorine atoms, and nitrogen heterocycles.*

FDA Label Image

Rof02 (Rof02)

A chart displaying fold changes in Cmax and AUC (with 90% confidence intervals) for Roflumilast and Roflumilast N-oxide caused by various substances. The graph includes recommendations such as 'Use With Caution,' 'No Dose Adjustment,' and 'Not Recommended' based on these interactions. The x-axis shows fold change relative to reference values.*

FDA Label Image

Rof03mcg-new-b (Rof03mcg New B)

Roflumilast Tablets 500 mcg oral tablets label showing a package of 30 tablets. The label includes dosage instructions, storage conditions, manufacturer information (Alkem Laboratories Ltd., Mumbai, India), and distributor details (Ascend Laboratories, LLC). The Ascend Laboratories logo is present, along with a barcode and product NDC portion 67877-480-30.*

FDA Label Image

Rof06-new-a (Rof06 New A)

Roflumilast Tablets 500 mcg oral dosage form label showing packaging for 90 tablets. The label includes the proprietary and generic name Roflumilast, dosage strength of 500 micrograms, dispensing instructions, and manufacturer Alkem Laboratories with distributor Ascend Laboratories, LLC. It also contains storage instructions, dosage guidance, a barcode, and prescription-only designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.